# Murphy USA Inc.: financial statements, quarterly

MUSA · NYSE · CIK 1573516 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/musa.md) · [Financials](/companies/musa/financials.md) · [Filings](/companies/musa/filings.md) · [Insiders](/companies/musa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/musa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,798](/filings/0001573516-24-000054.md) | [5,069 d](/filings/0001573516-24-000007.md) | [4,844](/filings/0001573516-25-000038.md) | [5,452](/filings/0001573516-25-000049.md) | [5,239](/filings/0001573516-25-000074.md) | [4,710 d](/filings/0001573516-26-000090.md) | [4,525](/filings/0001573516-26-000135.md) | [5,005](/filings/0001573516-26-000166.md) | [5,110](/filings/0001573516-25-000074.md) | [4,744 d](/filings/0001573516-26-000090.md) | [4,819](/filings/0001573516-26-000135.md) | [6,806](/filings/0001573516-26-000166.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [60.0](/filings/0001573516-24-000054.md) | [62.1 d](/filings/0001573516-26-000090.md) | [62.1](/filings/0001573516-25-000038.md) | [59.1](/filings/0001573516-25-000049.md) | [60.0](/filings/0001573516-25-000074.md) | [54.2 d](/filings/0001573516-26-000090.md) | [60.1](/filings/0001573516-26-000135.md) | [50.9](/filings/0001573516-26-000166.md) | [55.3](/filings/0001573516-25-000074.md) | [65.2 d](/filings/0001573516-26-000090.md) | [56.6](/filings/0001573516-26-000135.md) | [60.5](/filings/0001573516-26-000166.md) |
| Operating income | $m | [247](/filings/0001573516-24-000054.md) | [217 d](/filings/0001573516-26-000090.md) | [105](/filings/0001573516-25-000038.md) | [217](/filings/0001573516-25-000049.md) | [222](/filings/0001573516-25-000074.md) | [199 d](/filings/0001573516-26-000090.md) | [88.0](/filings/0001573516-26-000135.md) | [219](/filings/0001573516-26-000166.md) | [202](/filings/0001573516-25-000074.md) | [210 d](/filings/0001573516-26-000090.md) | [205](/filings/0001573516-26-000135.md) | [305](/filings/0001573516-26-000166.md) |
| Interest expense | $m | [24.6](/filings/0001573516-23-000049.md) | [24.0 d](/filings/0001573516-24-000007.md) | [24.9](/filings/0001573516-24-000036.md) | [24.9](/filings/0001573516-24-000046.md) | [24.4](/filings/0001573516-25-000074.md) | [22.9 d](/filings/0001573516-26-000090.md) | [25.4](/filings/0001573516-26-000135.md) | [27.8](/filings/0001573516-26-000166.md) | [29.1](/filings/0001573516-25-000074.md) | [28.6 d](/filings/0001573516-26-000090.md) | [29.0](/filings/0001573516-26-000135.md) | [29.3](/filings/0001573516-26-000166.md) |
| Income tax | $m | [55.7](/filings/0001573516-24-000054.md) | [46.3 d](/filings/0001573516-26-000090.md) | [15.9](/filings/0001573516-25-000038.md) | [48.4](/filings/0001573516-25-000049.md) | [49.5](/filings/0001573516-25-000074.md) | [35.3 d](/filings/0001573516-26-000090.md) | [8.7](/filings/0001573516-26-000135.md) | [46.9](/filings/0001573516-26-000166.md) | [43.5](/filings/0001573516-25-000074.md) | [39.5 d](/filings/0001573516-26-000090.md) | [39.9](/filings/0001573516-26-000135.md) | [68.5](/filings/0001573516-26-000166.md) |
| Net income | $m | [168](/filings/0001573516-24-000054.md) | [150 d](/filings/0001573516-26-000090.md) | [66.0](/filings/0001573516-25-000074.md) | [145](/filings/0001573516-25-000074.md) | [149](/filings/0001573516-25-000074.md) | [143 d](/filings/0001573516-26-000090.md) | [53.2](/filings/0001573516-26-000166.md) | [146](/filings/0001573516-26-000166.md) | [130](/filings/0001573516-25-000074.md) | [142 d](/filings/0001573516-26-000090.md) | [136](/filings/0001573516-26-000166.md) | [209](/filings/0001573516-26-000166.md) |
| Diluted EPS | $ per share | [7.69](/filings/0001573516-24-000054.md) | not reported | [3.12](/filings/0001573516-25-000038.md) | [6.92](/filings/0001573516-25-000049.md) | [7.20](/filings/0001573516-25-000074.md) | not reported | [2.63](/filings/0001573516-26-000135.md) | [7.36](/filings/0001573516-26-000166.md) | [6.76](/filings/0001573516-25-000074.md) | not reported | [7.28](/filings/0001573516-26-000135.md) | [11.27](/filings/0001573516-26-000166.md) |
| Basic EPS | $ per share | [7.83](/filings/0001573516-24-000054.md) | not reported | [3.17](/filings/0001573516-25-000038.md) | [7.02](/filings/0001573516-25-000049.md) | [7.30](/filings/0001573516-25-000074.md) | not reported | [2.67](/filings/0001573516-26-000135.md) | [7.44](/filings/0001573516-26-000166.md) | [6.83](/filings/0001573516-25-000074.md) | not reported | [7.36](/filings/0001573516-26-000135.md) | [11.34](/filings/0001573516-26-000166.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:Revenues
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [125](/filings/0001573516-23-000049.md) | [118](/filings/0001573516-25-000010.md) | [56.7](/filings/0001573516-24-000036.md) | [79.8](/filings/0001573516-24-000046.md) | [52.5](/filings/0001573516-24-000054.md) | [47.0](/filings/0001573516-26-000090.md) | [49.4](/filings/0001573516-25-000038.md) | [54.1](/filings/0001573516-25-000049.md) | [42.8](/filings/0001573516-25-000074.md) | [28.9](/filings/0001573516-26-000166.md) | [119](/filings/0001573516-26-000135.md) | [175](/filings/0001573516-26-000166.md) |
| Current assets | $m | [840](/filings/0001573516-23-000049.md) | [827](/filings/0001573516-25-000010.md) | [768](/filings/0001573516-24-000036.md) | [820](/filings/0001573516-24-000046.md) | [689](/filings/0001573516-24-000054.md) | [748](/filings/0001573516-26-000090.md) | [716](/filings/0001573516-25-000038.md) | [776](/filings/0001573516-25-000049.md) | [763](/filings/0001573516-25-000074.md) | [748](/filings/0001573516-26-000166.md) | [871](/filings/0001573516-26-000135.md) | [1,008](/filings/0001573516-26-000166.md) |
| Total assets | $m | [4,305](/filings/0001573516-23-000049.md) | [4,340](/filings/0001573516-26-000090.md) | [4,307](/filings/0001573516-24-000036.md) | [4,430](/filings/0001573516-24-000046.md) | [4,402](/filings/0001573516-24-000054.md) | [4,542](/filings/0001573516-26-000090.md) | [4,503](/filings/0001573516-25-000038.md) | [4,622](/filings/0001573516-25-000049.md) | [4,677](/filings/0001573516-25-000074.md) | [4,726](/filings/0001573516-26-000166.md) | [4,866](/filings/0001573516-26-000135.md) | [5,085](/filings/0001573516-26-000166.md) |
| Current liabilities | $m | [827](/filings/0001573516-23-000049.md) | [873](/filings/0001573516-25-000010.md) | [885](/filings/0001573516-24-000036.md) | [971](/filings/0001573516-24-000046.md) | [859](/filings/0001573516-24-000054.md) | [948](/filings/0001573516-26-000090.md) | [892](/filings/0001573516-25-000038.md) | [976](/filings/0001573516-25-000049.md) | [940](/filings/0001573516-25-000074.md) | [929](/filings/0001573516-26-000166.md) | [1,050](/filings/0001573516-26-000135.md) | [1,090](/filings/0001573516-26-000166.md) |
| Total liabilities | $m | [3,461](/filings/0001573516-23-000049.md) | [3,511](/filings/0001573516-25-000010.md) | [3,525](/filings/0001573516-24-000036.md) | [3,619](/filings/0001573516-24-000046.md) | [3,572](/filings/0001573516-24-000054.md) | [3,702](/filings/0001573516-26-000090.md) | [3,783](/filings/0001573516-25-000038.md) | [3,976](/filings/0001573516-25-000049.md) | [4,131](/filings/0001573516-25-000074.md) | [4,102](/filings/0001573516-26-000166.md) | [4,208](/filings/0001573516-26-000135.md) | [4,302](/filings/0001573516-26-000166.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [844](/filings/0001573516-24-000054.md) | [829](/filings/0001573516-26-000090.md) | [782](/filings/0001573516-25-000074.md) | [811](/filings/0001573516-25-000074.md) | [830](/filings/0001573516-25-000074.md) | [840](/filings/0001573516-26-000166.md) | [720](/filings/0001573516-26-000166.md) | [646](/filings/0001573516-26-000166.md) | [546](/filings/0001573516-25-000074.md) | [624](/filings/0001573516-26-000166.md) | [659](/filings/0001573516-26-000166.md) | [783](/filings/0001573516-26-000166.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [190 d](/filings/0001573516-24-000054.md) | [273 d](/filings/0001573516-26-000090.md) | [136](/filings/0001573516-25-000038.md) | [261 d](/filings/0001573516-25-000049.md) | [202 d](/filings/0001573516-25-000074.md) | [249 d](/filings/0001573516-26-000090.md) | [129](/filings/0001573516-26-000135.md) | [255 d](/filings/0001573516-26-000166.md) | [185 d](/filings/0001573516-25-000074.md) | [246 d](/filings/0001573516-26-000090.md) | [320](/filings/0001573516-26-000135.md) | [235 d](/filings/0001573516-26-000166.md) |
| Capital expenditure | $m | [79.4 d](/filings/0001573516-24-000054.md) | [111 d](/filings/0001573516-26-000090.md) | [76.2](/filings/0001573516-25-000038.md) | [118 d](/filings/0001573516-25-000049.md) | [137 d](/filings/0001573516-25-000074.md) | [127 d](/filings/0001573516-26-000090.md) | [87.8](/filings/0001573516-26-000135.md) | [118 d](/filings/0001573516-26-000166.md) | [117 d](/filings/0001573516-25-000074.md) | [117 d](/filings/0001573516-26-000090.md) | [98.3](/filings/0001573516-26-000135.md) | [112 d](/filings/0001573516-26-000166.md) |
| Dividends paid | $m | [8.4 d](/filings/0001573516-24-000054.md) | [8.7 d](/filings/0001573516-26-000090.md) | [8.8](/filings/0001573516-25-000038.md) | [9.1 d](/filings/0001573516-25-000049.md) | [9.2 d](/filings/0001573516-25-000074.md) | [9.7 d](/filings/0001573516-26-000090.md) | [9.8](/filings/0001573516-26-000135.md) | [9.8 d](/filings/0001573516-26-000166.md) | [10.1 d](/filings/0001573516-25-000074.md) | [11.8 d](/filings/0001573516-26-000090.md) | [11.7](/filings/0001573516-26-000135.md) | [11.8 d](/filings/0001573516-26-000166.md) |
| Share repurchases | $m | [64.8 d](/filings/0001573516-24-000054.md) | [161 d](/filings/0001573516-26-000090.md) | [86.4](/filings/0001573516-25-000038.md) | [106 d](/filings/0001573516-25-000049.md) | [125 d](/filings/0001573516-25-000074.md) | [128 d](/filings/0001573516-26-000090.md) | [150](/filings/0001573516-26-000135.md) | [214 d](/filings/0001573516-26-000166.md) | [219 d](/filings/0001573516-25-000074.md) | [66.9 d](/filings/0001573516-26-000090.md) | [70.5](/filings/0001573516-26-000135.md) | [82.3 d](/filings/0001573516-26-000166.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.7](/filings/0001573516-23-000049.md) | [22.1](/filings/0001573516-24-000036.md) | [22.1](/filings/0001573516-24-000046.md) | [21.8](/filings/0001573516-24-000054.md) | [21.2](/filings/0001573516-25-000038.md) | [20.9](/filings/0001573516-25-000049.md) | [20.7](/filings/0001573516-25-000074.md) | [20.2](/filings/0001573516-26-000135.md) | [19.8](/filings/0001573516-26-000166.md) | [19.2](/filings/0001573516-25-000074.md) | [18.7](/filings/0001573516-26-000135.md) | [18.6](/filings/0001573516-26-000166.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,380,347 at 2026-06-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001573516-26-000166.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.